Etiologic Agents and Antifungal Susceptibility of Oral Candidosis from Romanian patients with HIV-infection or type 1 diabetes mellitus

Pol J Microbiol. 2016;65(1):123-9. doi: 10.5604/17331331.1197327.

Abstract

This is the first Romanian investigation of oral candidosis in patients suffering of HIV-infection or type 1 diabetes mellitus (T1DM). Candida albicans was the dominant species in both types of isolates: n = 14 (46.7%) in T1DM, n = 60 (69.8%) in HIV. The most frequent non-albicans Candida spp. were Candida kefyr (n = 6; 20%) in T1DM and Candida dubliniensis (n = 8; 9.3%) in HIV. Resistance to fluconazole was detected only in the HIV non-albicans Candida group (n = 8; 9.3%). All isolates were susceptible to VOR. The experimental drug MXP had MIC values equal or close to the ones of VOR. Echinocandin resistance was more frequent than azole resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology*
  • Antifungal Agents / therapeutic use
  • Candida / classification
  • Candida / drug effects*
  • Candidiasis, Oral / microbiology*
  • Diabetes Complications / microbiology*
  • Diabetes Mellitus, Type 1
  • Drug Resistance, Fungal
  • Fluconazole / therapeutic use
  • HIV Infections / complications*
  • Humans
  • Microbial Sensitivity Tests
  • Romania / epidemiology
  • Triazoles / pharmacology

Substances

  • Antifungal Agents
  • Triazoles
  • Fluconazole